Chapter 4. Trade Composition and the World Trade Organization: The Effect of Intra-Industry Trade on the Dispute Settlement Procedure

2020 ◽  
pp. 68-94
2012 ◽  
Vol 42 (1) ◽  
pp. 75-100 ◽  
Author(s):  
Christophe Bonneuil ◽  
Les Levidow

The World Trade Organization (WTO) dispute settlement procedure is a key arena for establishing global legal norms for what counts as relevant knowledge. As a high-profile case, the WTO trade dispute on GMOs mobilized scientific expertise in somewhat novel ways. Early on, the Panel put the dispute under the Sanitary and Phytosanitary (SPS) Agreement through a new legal ontology; it classified transgenes as potential pests and limited all environmental issues to the ‘plant and animal health’ category. The selection of scientific experts sought a multi-party consensus through a fast adversarial process, reflecting a specific legal epistemology. For the SPS framing, focusing on the defendant’s regulatory procedures, the Panel staged scientific expertise in specific ways that set up how experts were questioned, the answers they would give, their specific role in the legal arena, and the way their statements would complement the Panel’s findings. In these ways, the dispute settlement procedure co-produced legal and scientific expertise within the Panel’s SPS framework. Moreover, the Panel operated a procedural turn in WTO jurisprudence by representing its findings as a purely legal-administrative judgement on whether the EC’s regulatory procedures violated the SPS Agreement, while keeping implicit its own judgements on substantive risk issues. As this case illustrates, the WTO settlement procedure mobilizes scientific expertise for sophisticated, multiple aims: it recruits a source of credibility from the scientific arena, thus reinforcing the standard narrative of ‘science-based trade discipline’, while also constructing new scientific expertise for the main task – namely, challenging trade restrictions for being unduly cautious.


2005 ◽  
Vol 99 (3) ◽  
pp. 389-400 ◽  
Author(s):  
B. PETER ROSENDORFF

The increased “legalization” embodied in the revised Dispute Settlement Procedure (DSP) of the World Trade Organization (WTO) is shown to be an institutional innovation that increases the opportunities for states to temporarily suspend their obligations in periods of unexpected, but heightened, domestic political pressure for protection. This increased flexibility in the system reduces per-period cooperation among states but also reduces the possibility that the regime may break down entirely. There is shown to be a trade-off between rigidity and stability in international institutional design in the face of unforeseen, but occasionally intense, domestic political pressure. In a model with a WTO that serves both an informational and adjudicatory role, it is established that agreements with DSPs are self-enforcing, are more stable, and are more acceptable to a wider variety of countries than agreements without DSPs. Evidence drawn from data on preferential trading agreements supports the key hypotheses.


2021 ◽  
pp. 1-17
Author(s):  
Muhammad ISLAM

The World Trade Organization (WTO) Agreement on the Application of Sanitary and Phytosanitary Measures (SPS Agreement) relies on scientific evidence as a conclusive risk assessment criterion, which ignores the inherent limitations of science. This article highlights certain trade-restrictive effects of scientific evidence and comments on the Agreement’s aversions to precautionary measures and the consumer concern of the harmful effects of biotech products that may be necessary to protect public health and biosecurity in many WTO Member States. These measures and concerns have become pressing issues due to surging consumer awareness and vigilance concerning environmental protection and food safety. The Agreement is yet to overcome the weaknesses of its endorsed international standardising bodies, the problematic definition of scientific evidence and treatment of justification for scientific risk assessment methods and the implementation difficulties faced by most developing states. This article analyses these issues under the provisions of the Agreement and the interpretations of the WTO Dispute Settlement Body in disputes involving SPS matters, which fall short of addressing scientific uncertainty surrounding biotech products and their associated risks.


Author(s):  
Sivan Shlomo Agon

The present chapter concludes the work. It sums up the key findings of the study while discussing the results emerging from a comparative analysis of the three categories of disputes examined throughout the book. The chapter then revisits the central arguments put forth in the book and articulates the lessons to be learned for the study of the goals, operation, and effectiveness of the World Trade Organization (WTO) Dispute Settlement System (DSS), and of international courts more broadly. It also discusses some of the insights to be offered with respect to possible institutional changes or reforms of the WTO DSS, with a view to ensuring the system’s future effectiveness. The chapter closes with several observations that go beyond effectiveness, pertaining to the costs and unintended consequences attendant on more effective and empowered international adjudication.


Sign in / Sign up

Export Citation Format

Share Document